Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Myeloid 1Genitourinary 1Classical hematology 1

Conditions

Prostatic Neoplasms 1Precancerous Conditions 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Anemia 1

Interventions

olaparib 2Epoetin Alfa 2Darbepoetin alfa 2Carboplatin 2venetoclax 1trametinib 1talazoparib 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1dehydroftorafur 1darolutamide 1dacomitinib 1dabrafenib 1copanlisib 1cobimetinib 1cabozantinib 1cabazitaxel 1bicalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Radioimmunodetection × Classical hematology × Clear all
NCT00899665 2014-02-11

Proteases in Patients With Prostate Cancer That Has Spread to the Bone

Barbara Ann Karmanos Cancer Institute

Completed
31 enrolled
Classical hematologyGenitourinaryMyeloidOther neoplasm

Anemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Neoplasm Metastasis, Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡